SLEEP - Sleep and Antibody Response to Hepatitis B Vaccination

SLEEP - Sleep and Antibody Response to Hepatitis B Vaccination

VOLUME 35, ISSUE 08

SLEEP AND ANTIBODY RESPONSE TO HEPATITIS B VACCINATION
Sleep and Antibody Response to Hepatitis B Vaccination

http://dx.doi.org/10.5665/sleep.1990

Aric A. Prather, PhD^1,2; Martica Hall, PhD³; Jacqueline M. Fury, BS¹; Diana C. Ross, MSN, RN¹; Matthew F. Muldoon, MD, MPH⁴; Sheldon Cohen, PhD⁵; Anna L. Marsland, PhD, RN^1
1Behavioral Immunology Laboratory, Department of Psychology, University of Pittsburgh, Pittsburgh, PA; ²Robert Wood Johnson Foundation Health and Society Scholar jointly appointed in the Center for Health and Community at the University of California, San Francisco and the School of Public Health at the University of California, Berkeley, CA; ³Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, PA; ⁴Center for Clinical Pharmacology, University of Pittsburgh School of Medicine; Department of Psychology, Carnegie Mellon University, Pittsburgh, PA; ⁵Department of Psychology, Carnegie Mellon University, Pittsburgh, PA

Study Objectives:

Experimental evidence links poor sleep with susceptibility to infectious illness; however, it remains to be determined if naturally occurring sleep is associated with immune responses known to play a role in protection against infection. The aim of this study was to determine whether sleep duration, sleep efficiency, and sleep quality, assessed in the natural environment, predict magnitude of antibody responses to a novel antigen among community volunteers in midlife.

Design:

Observational.

Measurements and Results:

Healthy midlife adults (n = 125; 70 female; age 40-60 yr) received the standard 3-dose hepatitis B vaccination series. Actigraphy and electronic sleep diaries were used to assess sleep duration, sleep efficiency, and subjective sleep quality. Viral-specific antibody titers were obtained prior to the 2nd and 3rd vaccination to assess primary and secondary antibody responses. Clinical protection status (anti-hepatitis B surface antigen immunoglobulin G ≥ 10 mIU/ml) was assessed 6 mo after the final immunization. Regression analyses revealed that shorter actigraphy-based sleep duration was associated with a lower secondary antibody response independent of age, sex, body mass index, and response to the initial immunization. Shorter sleep duration, measured by actigraphy and sleep diary, also predicted a decreased likelihood of being clinically protected from hepatitis B at the conclusion of the vaccination series. Neither sleep efficiency nor subjective sleep quality were significant predictors of antibody response.

Conclusions:

Short sleep duration in the natural environment may negatively affect in vivo antibody responses to novel antigens, providing a possible explanation for observed associations of poor sleep with increased susceptibility to infectious disease.

Citation:

Prather AA; Hall M; Fury JM; Ross DC; Muldoon MF; Cohen S; Marsland AL. Sleep and antibody response to hepatitis B vaccination. SLEEP 2012;35(8):1063-1069.

VOLUME 35, ISSUE 08

Previous Article

Next Article

Sleep and Infectious Disease Risk. 1025-1026.
Michael R. Irwin, MD

ASL Imaging of Brain Function Changes During Sleep Restriction. 1027-1028.
Hengyi Rao, PhD

Sleep, Circadian Rhythms, and Critical Illness. 1029-1030.
Sairam Parthasarathy, MD^1,2; Randall Friese, MD³

Connecting the Dots: From Trait Vulnerability during Total Sleep Deprivation to Individual Differences in Cumulative Impairment during Sustained Sleep Restriction. 1031-1033.
Hans P.A. Van Dongen, PhD

Aging, Subjective Sleep Quality, and Health Status: The Global Picture. 1035-1036.
Yohannes Endeshaw, MD, MPH

Update to the AASM Clinical Practice Guideline: “The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses”. 1037.
R. Nisha Aurora, MD¹; David A. Kristo, MD²; Sabin R. Bista, MD³; James A. Rowley, MD⁴; Rochelle S. Zak, MD⁵; Kenneth R. Casey, MD, MPH⁶; Carin I. Lamm, MD⁷; Sharon L. Tracy, PhD⁸; Richard S. Rosenberg, PhD⁸

The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses. 1039-1062.
R. Nisha Aurora, MD¹; David A. Kristo, MD²; Sabin R. Bista, MD³; James A. Rowley, MD⁴; Rochelle S. Zak, MD⁵; Kenneth R. Casey, MD, MPH⁶; Carin I. Lamm, MD⁷; Sharon L. Tracy, PhD⁸; Richard S. Rosenberg, PhD⁸

Sleep and Antibody Response to Hepatitis B Vaccination. 1063-1069.
Aric A. Prather, PhD^1,2; Martica Hall, PhD³; Jacqueline M. Fury, BS¹; Diana C. Ross, MSN, RN¹; Matthew F. Muldoon, MD, MPH⁴; Sheldon Cohen, PhD⁵; Anna L. Marsland, PhD, RN¹

Differential Effects of Sodium Oxybate and Baclofen on EEG, Sleep, Neurobehavioral Performance, and Memory. 1071-1083.
Julie Vienne, PhD¹; Gianpaolo Lecciso²; Irina Constantinescu, PhD³; Sophie Schwartz, PhD^3,4; Paul Franken, PhD¹; Raphaël Heinzer, MD²; Mehdi Tafti, PhD^1,2

Cerebral Perfusion Differences Between Drowsy and Nondrowsy Individuals After Acute Sleep Restriction. 1085-1096.
Govinda R. Poudel, PhD^1,2; Carrie R. H. Innes, PhD^1,2; Richard D. Jones, PhD^1,2,3,4,5

The Orexin Antagonist SB-649868 Promotes and Maintains Sleep in Men with Primary Insomnia. 1097-1104.
Paolo Bettica, MD, PhD¹; Lisa Squassante, PhD²; Stefano Zamuner, PhD³; Gianluca Nucci, PhD³; Heidi Danker-Hopfe, PhD⁴; Emiliangelo Ratti, PhD⁵

Temporal Disorganization of Circadian Rhythmicity and Sleep-Wake Regulation in Mechanically Ventilated Patients Receiving Continuous Intravenous Sedation. 1105-1114.
Brian K. Gehlbach, MD¹; Florian Chapotot, PhD³; Rachel Leproult, PhD³; Harry Whitmore, RPSGT³; Jason Poston, MD²; Mark Pohlman, MD²; Annette Miller, RN, MSN³; Anne S. Pohlman, RN, MSN²; Arlet Nedeltcheva, MD³; John H. Jacobsen, MD⁴; Jesse B. Hall, MD²; Eve Van Cauter, PhD³

Effects of Age, Gender, and Retirement on Perceived Sleep Problems: Results from the VISAT Combined Longitudinal and Cross-Sectional Study. 1115-1121.
Jean-Claude Marquiáe, PhD¹; Simon Folkard, PhD, DSc^2,3,4; David Ansiau, PhD³; Philip Tucker, PhD⁴

Accommodating Adolescent Sleep-Wake Patterns: The Effects of Shifting the Timing of Sleep on Training Effectiveness. 1123-1136.
Nita Lewis Miller, PhD; Anthony P. Tvaryanas, MD, PhD; Lawrence G. Shattuck, PhD

Deterioration of Neurobehavioral Performance in Resident Physicians During Repeated Exposure to Extended Duration Work Shifts. 1137-1146.
Clare Anderson, PhD^1,2; Jason P. Sullivan¹; Erin E. Flynn-Evans, PhD^1,2; Brian E. Cade, PhD^1,2; Charles A. Czeisler, MD, PhD^1,2; Steven W. Lockley, PhD^1,2

Snoring and Severity of Symptomatic and Asymptomatic Carotid Stenosis: A Population-Based Study. 1147-1151.
Rebecca H. Mason, MBChB¹; Ziyah Mehta, DPhil²; Ana Catarina Fonseca, MD²; John R. Stradling, MD¹; Peter M. Rothwell, PhD²

Residual Sleep Disturbances in Patients Remitted From Major Depressive Disorder: A 4-Year Naturalistic Follow-up Study. 1153-1161.
Shirley X. Li, MA, RPSGT; Siu P. Lam, MRCPsych, FHKAM (Psych); Joey W. Y. Chan, MBChB; Mandy W. M. Yu, MPH, RPSGT; Yun-Kwok Wing, FRCPsych, FHKAM (Psych)

Trait-Like Vulnerability to Total and Partial Sleep Loss. 1163-1172.
Tracy L. Rupp, PhD; Nancy J. Wesensten, PhD; Thomas J. Balkin, PhD

Sleep Problems: An Emerging Global Epidemic? Findings From the INDEPTH WHO-SAGE Study Among More Than 40,000 Older Adults From 8 Countries Across Africa and Asia. 1173-1181.
Saverio Stranges, MD, PhD¹; William Tigbe, MD, PhD¹; Francesc Xavier Gómez-Olivé, MD^2,3; Margaret Thorogood, PhD^1,2,3; Ngianga-Bakwin Kandala, PhD¹

Erratum. 1183.

Table of Contents